Artimplant AB's Year-end Results, January 1-December 31, 2004
17. Februar 2005 03:02 ET
|
Artimplant
STOCKHOLM, Sweden, Feb. 17, 2005 (PRIMEZONE) -- Artimplant:
-- Artimplant's net sales for the full year 2004 reached SEK 4.82
millions (1.2)
-- Losses after tax amounted to SEK 42.1...
Artimplant and Biomet Sign Development and License Agreement
14. Dezember 2004 01:52 ET
|
Artimplant
STOCKHOLM, Sweden, Dec. 14, 2004 (PRIMEZONE) -- Artimplant AB, a Swedish publicly traded biomaterials and orthobiologics company, and Biomet, a worldwide leader in the design, manufacture and...
Artimplant Partners With Avanta for Sales of Artelon CMC-I Spacer
02. Dezember 2004 02:36 ET
|
Artimplant
STOCKHOLM, Sweden, Dec. 2, 2004 (PRIMEZONE) -- Artimplant, a Swedish biomaterials and orthobiologics company, and Avanta Orthopedics, a leader in the small joint market specialized in hand surgery,...
Artimplant: A new Artelon(R) Surgical Suture available in Europe
08. November 2004 09:58 ET
|
Artimplant
STOCKHOLM, Sweden, Nov. 8, 2004 (PRIMEZONE) -- Artimplant AB, a Swedish biomaterials and orthobiologics company, has been granted CE-certification for a thicker and stronger -- size 2 -- Artelon(R)...
Artimplant AB's Interim Report January 1 -- September 30, 2004
05. November 2004 02:36 ET
|
Artimplant
STOCKHOLM, Sweden, Nov. 5, 2004 (PRIMEZONE) -- Artimplant:
- Artimplant's net sales for the 9 month period reached SEK 1.1 million (SEK 1.2 million)
- Losses after tax amounted to SEK -22.4...
Development Cooperation Between Artimplant and Molnlycke Health Care Terminated
04. Oktober 2004 10:25 ET
|
Artimplant
STOCKHOLM, Sweden, Oct. 4, 2004 (PRIMEZONE) -- The contract between Artimplant and Molnlycke Health Care concerning development and licensing of products for wound healing has been...
Artimplant's Artelon CMC-I Spacer Cleared by FDA
23. September 2004 01:50 ET
|
Artimplant
STOCKHOLM, Sweden, Sept. 23, 2004 (PRIMEZONE) -- Artimplant, a biomaterials and orthobiologics company based in Gothenburg, Sweden, has received FDA clearance through a 510(k) for its Artelon(r)...
Artimplant AB's Interim Report January 1 - JUNE 30, 2004
27. August 2004 03:49 ET
|
Artimplant
STOCKHOLM, Sweden, Aug. 27, 2004 (PRIMEZONE) -- Highlights of Artimplant AB's Interim Report January 1 - JUNE 30, 2004:
Increased Sales Efforts and Continued Strong Cash Position
- Artimplant's...
Artimplant AB's Interim Report January 1- March 31, 2004
27. April 2004 03:16 ET
|
Artimplant
STOCKHOLM, Sweden, April 27, 2004 (PRIMEZONE) -- Artimplant AB:
Several New Regulatory Approvals and a Strong Financial Position
-- Artimplant's net sales for the period reached SEK 1.0 million...
Artimplant and Carnegie Mellon University in research collaboration
21. April 2004 03:10 ET
|
Artimplant
STOCKHOLM, Sweden, April 21, 2004 (PRIMEZONE) -- Artimplant and Carnegie Mellon University in research collaboration on Artelon(R) in bone applications.
Artimplant, a biomaterials and...